• 12 Oct, 2026
• UnityPain
• No comment

CGRP Treatment for Chronic Migraine | Unity Pain

Understanding CGRP Treatment for Chronic Migraine

If you have been living with chronic migraine, you know how much it can take from you. The lost days at work. The missed birthday parties. The fear of waking up with another headache that will steal hours — or even days — from your life. You are not alone, and your pain is real. In recent years, a newer type of treatment called CGRP therapy has given many people with chronic migraine a real reason for hope. Understanding how it works may help you have a more informed conversation with your doctor about your options.

What Is Chronic Migraine?

Migraine is more than a bad headache. It is a neurological condition that can cause intense throbbing pain, nausea, vomiting, and sensitivity to light and sound. Doctors define chronic migraine as having 15 or more headache days per month, with at least 8 of those days meeting migraine criteria, for three months or longer. This is different from episodic migraine, which happens less often.

Chronic migraine affects a person’s quality of life in deep ways. Many people find that standard pain medications stop working well over time, or that taking them too often can actually make headaches worse — a problem called medication overuse headache. This cycle can feel discouraging and exhausting. That is why researchers have worked hard to find treatments that target the root causes of migraine rather than just the symptoms.

What Is CGRP and Why Does It Matter?

CGRP stands for calcitonin gene-related peptide. It is a protein found naturally in the nervous system. Research has shown that CGRP levels rise significantly during a migraine attack. CGRP causes blood vessels in the brain to widen and plays a role in sending pain signals. Scientists believe that too much CGRP activity is a key part of what makes migraines happen and feel so severe.

Because of this connection, researchers developed medications that specifically target CGRP. These drugs either block CGRP itself or block the receptors that CGRP attaches to in the body. By interrupting this process, the medications may reduce how often migraines happen and how bad they feel. This was a major step forward because older migraine treatments were not designed with this specific pathway in mind.

Types of CGRP Treatments Available

There are two main categories of CGRP treatments. The first group is used for prevention — to reduce how often migraines occur. These are given as monthly or quarterly injections and include medications such as erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), and eptinezumab (Vyepti). Many patients give themselves these injections at home using a simple auto-injector device.

The second category is used for acute treatment — meaning you take them when a migraine is already starting. These are called gepants and include medications such as ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT). Rimegepant has also been approved for preventive use, making it useful in both categories. Your doctor can help determine which type — or combination — might be right for your situation.

What Does the Research Say?

Clinical trials have shown that CGRP-targeting medications can reduce the number of monthly migraine days in many people with chronic migraine. Some patients in studies experienced a significant reduction in headache frequency, though results vary from person to person. These treatments do not work the same way for everyone, and no treatment can be guaranteed to eliminate migraines completely.

One important advantage of CGRP therapies is their side effect profile. Compared to some older preventive medications — like certain antidepressants, blood pressure drugs, or anti-seizure medications — CGRP treatments tend to cause fewer side effects for many patients. The most commonly reported side effects include injection site reactions and, with erenumab, constipation in some users. Talking with a healthcare provider about your full medical history is important before starting any new medication.

Who Might Benefit from CGRP Therapy?

CGRP therapy is generally considered for people who have not gotten enough relief from other migraine treatments, or who have had difficulty tolerating older preventive medications. It may also be an option for people who experience medication overuse headache and need an alternative approach. A thorough evaluation by a qualified provider is the best way to know if this type of treatment is appropriate for you.

Insurance coverage for CGRP medications has expanded significantly, though prior authorization is often required. The process can feel confusing, but many clinics and specialty pharmacies have staff who can help navigate coverage requirements. At Unity Pain Management in Modesto, CA, the team is experienced in working with insurance plans and can help guide patients through the process of exploring their options for chronic pain and headache care.

What to Expect When Talking to Your Provider

When you meet with a provider to discuss CGRP treatment, it helps to come prepared. Keep a headache diary in the weeks before your appointment. Track how many headache days you have each month, how severe they are, what seems to trigger them, and what medications you have already tried. This information helps your provider understand your full picture and make a more informed recommendation.

Your provider will also want to review your medical history, other medications you take, and any other health conditions you have. CGRP therapy is not right for everyone, and a careful evaluation helps ensure you receive care that is safe and appropriate for your needs. If you are unsure where to start, a telehealth visit can be a convenient first step to discuss your migraine history and explore what treatment paths may be available to you.

A Reason for Hope

Living with chronic migraine is hard. If you have tried treatment after treatment without enough relief, it is natural to feel worn down. But medicine continues to advance, and CGRP therapy represents one of the most meaningful breakthroughs in migraine care in decades. Many people who had given up hope have found real improvement with these newer options.

You deserve support from a team that takes your pain seriously. Whether you are just starting to explore your options or are ready to take the next step, consider reaching out to Unity Pain Management in Modesto, CA to learn more about how today’s pain care options might help you reclaim more of your life. Relief may not be guaranteed, but a thoughtful, personalized plan can make a meaningful difference.

References

• Dodick, David W. “CGRP Ligand and Receptor Monoclonal Antibodies for Migraine Prevention.” Headache: The Journal of Head and Face Pain. 2019.
• Ashina, Messoud. “Migraine.” New England Journal of Medicine. 2020.
• National Institute of Neurological Disorders and Stroke. “Migraine Information Page.” National Institutes of Health. 2023.
• American Headache Society. “The American Headache Society Position Statement on Integrating New Migraine Treatments into Clinical Practice.” Headache. 2019.
• Mayo Clinic Staff. “Migraine — Diagnosis and Treatment.” Mayo Clinic. 2023.